ADC Therapeutics ADCT
NYSE ADCT
$1.52 +0.08 (+5.90%)
As of: Oct 20, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Short term Debt (2020 - 2026)

Updated

ADC Therapeutics (ADCT) posted Short term Debt of $6.2 million for Q2 2026, up 33.8% from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Short term Debt (2020 - 2026) Analysis & Trends

At the end of FY2025, ADC Therapeutics' Short term Debt came in at $3 million.

  • Annual Short term Debt shows a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
  • In prior years, ADC Therapeutics' Short term Debt was $12.47 million in FY2022 (+89.7%) and $6.58 million in FY2021 (+81.1%).
  • The Q2 2026 figure stands as the highest quarterly Short term Debt since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 ADC Therapeutics 235.62 Mn -710.57 Mn 16.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.20 Mn
Mar 31, 2026 4.64 Mn
Dec 31, 2025 3.00 Mn
Dec 31, 2022 12.47 Mn
Jun 30, 2022 6.57 Mn
Mar 31, 2022 6.55 Mn
Dec 31, 2021 6.58 Mn
Sep 30, 2021 6.58 Mn
Jun 30, 2021 6.19 Mn
Mar 31, 2021 3.59 Mn
Dec 31, 2020 3.63 Mn
API Access

ADC Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ADCT&period=max&api_key=YOUR_API_KEY